Synaffix Expands Partnership Horizon with Boehringer Ingelheim
January 9, 2025 - 17:10
In a significant move to enhance its portfolio, Synaffix, a leader in antibody-drug conjugate (ADC) technology, has entered into a new licensing agreement with Boehringer Ingelheim. This partnership allows Boehringer to leverage Synaffix's advanced ADC technologies for a specified number of cancer targets, although the exact details regarding the number of targets remain confidential.
This agreement marks a strategic step for Synaffix as it continues to build on its momentum from last year, when it secured several partnerships. Additionally, Synaffix has expanded its collaboration network by forming a technology licensing deal with Mitsubishi Tanabe Pharma in Japan. These developments underscore Synaffix's commitment to advancing cancer treatment options through innovative ADC technologies.
As the landscape of cancer therapeutics evolves, this collaboration with Boehringer Ingelheim is poised to accelerate the development of novel ADC therapies, potentially leading to more effective treatment solutions for patients battling cancer.
MORE NEWS
April 24, 2026 - 04:02
Next Technology Drive Construction to Cause Weekend Traffic Disruptions in MadisonMADISON, AL – Motorists in Madison should prepare for significant traffic disruptions along Next Technology Drive this weekend as construction crews begin a new phase of roadway improvements. The...
April 23, 2026 - 00:48
AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICERAmgen has announced the retirement of Dr. David M. Reese, the company`s Executive Vice President and Chief Technology Officer. The decision is effective as of the end of this year, concluding a...
April 22, 2026 - 12:12
Japan lowers restrictions on weapon and technology exportsIn a historic policy shift, the Japanese government has approved a sweeping revision to its strict defense export controls, effectively lifting a decades-long ban on selling lethal weapons abroad....
April 21, 2026 - 17:12
Technology Guide: Modern cellular analysis in early drug discoveryThe initial stages of drug discovery are being transformed by a new generation of cellular analysis technologies. By moving beyond traditional, one-dimensional assays, scientists are now able to...